CardioMetabolic Essential

This test is one of Boston Heart's 3 curated cardiometabolic profiles. Since most adults have some degree of cardiometabolic risk, these profiles have been designed to evaluate and monitor the extent of this risk in your patients.

Cardiovascular disease, type 2 diabetes, metabolic syndrome, and obesity are widespread and very common among patients. These lifestyle diseases are largely preventable, treatable, and reversible. The right combination of blood tests can unmask and monitor risk for serious health problems including premature death and dramatically reduced quality of life.

Routine lipid testing is insufficient to identify and monitor patients’ cardiometabolic risk adequately.

Monitoring glucose and HbA1c is critical for the prevention, early identification, treatment, and reversal of type 2 diabetes and cardiovascular risk.

Atherosclerosis is an inflammatory disease. After ruling out other causes of inflammation, C-reactive protein (CRP) is a strong independent predictor of CVD. Lowering CRP with statins in patients with normal LDL-C reduces CVD events. Inflammation can be reduced by losing weight if appropriate, normalizing lipids, glucose and blood pressure, eliminating tobacco and processed foods, making healthier dietary choices and increasing exercise and restful sleep.

Electrolytes, kidney function, liver function and other measures of normal metabolic activity are valuable tools for health assessment and patient management.

Freeze the provided ice packs for 24 hours before your blood draw.

Fast for 8-12 hours before your blood draw. You may drink only water, black coffee, or tea without dairy or sugar.

Hydrate before your blood draw.